Tema Heart & Health ETF (HRTS) price, chart and fund profile
Price chart
Fund profile
HRTS is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
- Issuer
- Tema Global Ltd.
- Industry
- Healthcare
- Inception
- Nov 20, 2023
- Assets under management
- $56.0M
- Expense ratio
- 0.75%
- Net asset value
- $37.58
- NAV as of
- Aug 28, 2026
- Leverage
- 1×
- Fund page
- temaetfs.com↗
Frequently asked questions
What is Tema Heart & Health ETF (HRTS)?
HRTS is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
What is HRTS's expense ratio?
Tema Heart & Health ETF charges an annual expense ratio of 0.75%. The fund is issued by Tema Global Ltd..
How large is HRTS?
Tema Heart & Health ETF manages $56.0M in assets and has traded since Nov 20, 2023.
How do I buy shares of Tema Heart & Health ETF (HRTS)?
HRTS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
